FDA Approved: EPLERENONE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for eplerenone from Mylan Pharmaceuticals, updating the approved product label for this generic drug (NDA 021437).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hypertension

Drugs mentioned

• eplerenone (eplerenone)

Snippet

SUPPL AP for EPLERENONE (EPLERENONE)